Related Experiment Video

Updated: Aug 11, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement

Sophia N Kalantaridou1, Katerina K Naka, Aris Bechlioulis

  • 1Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, and Michaeleidion Cardiac Center, University of Ioannina Medical School, 45110 Ioannina, Greece. sophia_kalantaridou@hotmail.com

Trends in Endocrinology and Metabolism: TEM
|March 7, 2006
PubMed

Insights

Hormone replacement therapy may improve vascular endothelial function in women with premature ovarian failure, reducing cardiovascular disease risk. Further research is needed on long-term effects and optimal hormone therapy strategies.

Area of Science:

  • Reproductive Endocrinology
  • Cardiovascular Medicine
  • Vascular Biology

Background:

  • Cardiovascular disease (CVD) is the leading cause of death in women.
  • Vascular endothelial dysfunction is an early indicator of atherosclerosis.
  • Premature ovarian failure (POF) increases CVD risk due to early vascular dysfunction linked to sex steroid deficiency.

Purpose of the Study:

  • To assess the long-term cardiovascular and overall prognosis in young women with POF.
  • To evaluate the effects of hormone replacement therapy (HRT) on endothelial function in these women.
  • To investigate optimal HRT parameters (dose, duration, route) for managing CVD risk in POF.

Main Methods:

  • Review of studies on HRT in young women with POF.
  • Analysis of endothelial function markers in relation to HRT.
  • Assessment of cardiovascular outcomes and overall prognosis.

Main Results:

  • Cyclical estrogen and progestogen therapy has demonstrated the ability to restore endothelial function.
  • HRT shows potential in mitigating early vascular endothelial dysfunction associated with POF.

Conclusions:

  • HRT may be beneficial for improving vascular health in young women with POF.
  • More research is essential to determine the long-term cardiovascular benefits and ideal HRT regimens for this population.

More Related Videos

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery07:40

Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery

Published on: May 16, 2018

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...